コンテンツにジャンプ

トップページ > 研究組織一覧 > 分野・独立ユニットグループ > 希少がん研究分野 > 発表業績 > 論文発表 > 1．Original paper（English）（249 papers）

1．Original paper（English）（249 papers）

2024

  1. Ono T, Kodera Y, Kondo T. Data for proteomic analysis of sarcoma spheroids cultured with perfusion and without perfusion. Journal of Proteome Data and Methods. 2024 Mar. accepted.
  2. Adachi Y, Noguchi R, Yoshimatsu Y, Sin Y, Osaki J, Ono T, Iwata S, Akiyama T, Tsuchiya R, Toda Y, Ishihara S, Ogura K, Kobayashi E, Kojima N, Yoshida A, Yokoo H, Kawai A, Kondo T. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1. Hum Cell. 2024 May;37(3):874-885. doi: 10.1007/s13577-024-01042-5. Epub 2024 Mar 11. PMID: 38466561. [PubMed] (外部リンク)
  3. Osaki J, Noguchi R, Yanagihara K, Ono T, Adachi Y, Iwata S, Toda Y, Sekita T, Kobayashi E, Kojima N, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma. Hum Cell. 2024 May;37(3):865-873. doi: 10.1007/s13577-024-01039-0. Epub 2024 Mar 13. PMID: 38478355. [PubMed] (外部リンク)
  4. Ono T, Noguchi R, Osaki J, Akiyama T, Adachi Y, Kojima N, Toda Y, Fukushima S, Yoshimatsu Y, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line. Hum Cell. 2024 May;37(3):854-864. doi: 10.1007/s13577-024-01030-9. Epub 2024 Feb 19. PMID: 38372888. [PubMed] (外部リンク)
  5. Takane K, Cai T, Noguchi R, Gohda Y, Ikenoue T, Yamaguchi K, Ota Y, Kiyomatsu T, Yano H, Fukuyo M, Seki M, Rahmutulla B, Kaneda A, Furukawa Y.  Genome-wide analysis of DNA methylation in pseudomyxoma peritonei originated from appendiceal neoplasms.Oncology. 2024;102(8):720-731. doi: 10.1159/000536219. Epub 2024 Jan 23. PMID: 38262376. [PubMed] (外部リンク)
  6. Osaki J, Noguchi R, Ono T, Adachi Y, Iwata S, Toda Y, Funada T, Iwata S, Kojima N, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-SS6-C1: a novel patient-derived cell line of synovial sarcoma. Hum Cell. 2024 Aug 23. doi: 10.1007/s13577-024-01122-6. Epub ahead of print. PMID: 39174825. [PubMed] (外部リンク)
  7. Adachi Y, Noguchi R, Osaki J, Ono T, Iwata S, Akiyama T, Tsuchiya R, Toda Y, Sekita T, Iwata S, Kobayashi E, Kojima N, Yoshida A, Yokoo H, Kawai A, Kondo T. Establishment and characterization of two novel patient-derived cell lines from myxofibrosarcoma: NCC-MFS7-C1 and NCC-MFS8-C1. Hum Cell. 2024 Aug 31. doi: 10.1007/s13577-024-01124-4. Epub ahead of print. PMID: 39214957. [PubMed] (外部リンク)
  8. Noguchi R, Osaki J, Ono T, Adachi Y, Iwata S, Yoshimatsu Y, Sasaki K, Kawai A, Kondo T. Pharmacoproteogenomic Approach Identifies On-Target Kinase Inhibitors for Cancer Drug Repositioning. In Vitro Cellular & Developmental Biology - Animal. 2024 Oct 18. doi: 10.1007/s11626-024-00983-3. Epub ahead of print. PMID: 39422823. [PubMed] (外部リンク)
  9. Ono T, Ono Y, Kondo T. Proteome analysis of murine organs using Auto2D. J Electrophoresis 68 (1):7-13. DOI:10.2198/jelectroph.68.7 [J-Stage] (外部リンク)
  10. Iwata S, Ono T, Noguchi R, Osaki J, Adachi Y, Shiota Y, Iwata S, Nishino S, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-GCTB14-C1 and NCC-GCTB15-C1: two novel patient-derived cell lines of giant cell tumor of bone. Hum Cell. 2024 Nov 27;38(1):20. doi: 10.1007/s13577-024-01150-2. PMID: 39604602. [PubMed] (外部リンク)
  11. Adachi Y, Noguchi R, Osaki J, Ono T, Iwata S, Akiyama T, Kondo H, Kobayashi E, Kojima N, Yoshida A, Yokoo H, Kawai A, Kondo T. Establishment and characterization of NCC-GCTB10-C1: a novel cell line derived from a patient with recurrent giant cell tumor of bone. Human Cell. 2024 Nov 19th accepted.
  12. Noguchi R, Ono T, Osaki J, Adachi Y, Iwata S, Shiota Y, Yanagihara K, Nishino S, Funada T, Ogura K, Yoshida A, Kawai A, Kondo T.Establishment and characterization of a novel patient-derived cell line from conventional central grade 3 chondrosarcoma, NCC-CS1-C1. Human Cell. 2024 Dec 8;38(1):28. doi: 10.1007/s13577-024-01152-0. PMID: 39645627. [PubMed] (外部リンク)

2023

  1. Noguchi R, Yoshimatsu Y, Sin Y, Ono T, Tsuchiya R, Yoshida H, Kiyono T, Yonemura Y, Kondo T. Establishment and characterization of NCC-PMP2-C1: a novel patient-derived cell line of pseudomyxoma peritonei with signet ring cells. Hum Cell. 2024 Mar;37(2):511-522. doi: 10.1007/s13577-023-01015-0. Epub 2023 Dec 25. PMID: 38143259.  [PubMed] (外部リンク)
  2. Yoshimatsu Y, Noguchi R, Osaki J, Sin Y, Tsuchiya R, Ono T, Akiyama T, Adachi Y, Tanzawa Y, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-LMS3-C1: a novel patient-derived cell line of leiomyosarcoma. Hum Cell. 2024 Jan;37(1):337-344. doi: 10.1007/s13577-023-00991-7. Epub 2023 Oct 31. PMID: 37907774. [PubMed] (外部リンク)
  3. Horie M, Takagane K, Itoh G, Kuriyama S, Yanagihara K, Yashiro M, Umakoshi M, Goto A, Arita J, Tanaka M. Exosomes secreted by ST3GAL5 high cancer cells promote peritoneal dissemination by establishing a premetastatic microenvironment. Mol Oncol. 2024 Jan;18(1):21-43. doi: 10.1002月18日78-0261.13524. Epub 2023 Sep 27. PMID: 37716915; PMCID: PMC10766203. [PubMed] (外部リンク)

  4. Takahashi S, Takagane K, Itoh G, Kuriyama S, Umakoshi M, Goto A, Yanagihara K, Yashiro M, Iijima K, Tanaka M. CCDC85A is regulated by miR-224-3p and augments cancer cell resistance to endoplasmic reticulum stress. Front Oncol. 2023 Jul 18;13時11分96546. doi: 10.3389/fonc.2023.1196546. PMID: 37534255; PMCID: PMC10391547. [PubMed]（外部リンク）

  5. Kitajima H, Maruyama R, Niinuma T, Yamamoto E, Takasawa A, Takasawa K, Ishiguro K, Tsuyada A, Suzuki R, Sudo G, Kubo T, Mitsuhashi K, Idogawa M, Tange S, Toyota M, Yoshido A, Kumegawa K, Kai M, Yanagihara K, Tokino T, Osanai M, Nakase H, Suzuki H. TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells. Cell Death Dis. 2023 Jul 13;14(7):424. doi: 10.1038/s41419-023-05953-3. PMID: 37443145; PMCID: PMC10345132. [PubMed] (外部リンク)

  6. Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Osaki J, Ono T, Adachi Y, Tsuchiya R, Toda Y, Ogura K, Kojima N, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-DFSP4-C1: a novel cell line from a patient with dermatofibrosarcoma protuberans having the fibrosarcomatous transformation. Hum Cell. 2023 Nov;36(6):2187-2194. doi: 10.1007/s13577-023-00932-4. Epub 2023 Jul 25. PMID: 37490236. [PubMed]（外部リンク）
  7. Ono T, Noguchi R, Yoshimatsu Y, Sin Y, Tsuchiya R, Akiyama T, Kojima N, Toda Y, Sato C, Fukushima S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone. Hum Cell. 2023 Sep;36(5):1804-1812. doi: 10.1007/s13577-023-00928-0. Epub 2023 Jun 17. PMID: 37328637. [PubMed] (外部リンク)
  8. Tsuchiya R, Yoshimatsu Y, Noguchi R, Sin Y, Ono T, Akiyama T, Kosako H, Yoshida A, Ohtori S, Kawai A, Kondo T. Integrating analysis of proteome profile and drug screening identifies therapeutic potential of MET pathway for the treatment of malignant peripheral nerve sheath tumor. Expert Rev Proteomics. 2023 Apr-Jun;20(4-6):109-119. doi: 10.1080/14789450.2023.2218035. Epub 2023 May 29. PMID: 37229542. [PubMed] (外部リンク)
  9. Noguchi R, Kosako H, Sasaki K, Kondo T. Data for proteogenomic analysis of two patient-derived undifferentiated pleomorphic sarcoma cell lines. Journal of Proteome Data and Methods. 2023 June;5. doi: https://doi.org/10.14889/jpdm.2023.0013. [J-STAGE]（外部リンク）
  10. Ono T, Kondo T. Data of distinct stromal protein expressions between sarcoma patient-derived models and their primary tumors. Journal of Proteome Data and Methods. 2023 Apr;5. doi: https://doi.org/10.14889/jpdm.2023.0011. [J-STAGE]（外部リンク）
  11. Isoyama S, Tamaki N, Noguchi Y, Okamura M, Yoshimatsu Y, Kondo T, Suzuki T, Yaguchi S, Dan S. Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors. Cell Death Dis. 2023 Feb 27;14(2):169. doi: 10.1038/s41419-023-05690-7. PMID: 36849535; PMCID: PMC9971170. [PubMed] (外部リンク)
  12. Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Osaki J, Ono T, Adachi Y, Tsuchiya R, Toda Y, Kobayashi E, Kojima N, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-DSM1-C1: a novel cell line derived from a patient with desmoid fibromatosis. Hum Cell. 2023 Mar;36(2):847-853. doi:10.1007/s13577-022-00850-x. Epub 2023 Jan 11. PMID: 36629983. [PubMed] (外部リンク)
  13. Noguchi R, Yoshimura A, Uchino J, Takeda T, Chihara Y, Ota T, Hiranuma O, Gyotoku H, Takayama K, Kondo T. Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations. Proteomes. 2023 Feb 5;11(1):6. doi: 10.3390/proteomes11010006. PMID: 36810562; PMCID: PMC9944465. [PubMed]（外部リンク)
  14. Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Osaki J, Adachi Y, Ono T, Tsuchiya R, Sato C, Iwata S, Kojima N, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-PLPS2-C1: a novel cell line of pleomorphic liposarcoma. Hum Cell. 2023 Jan;36(1):468-475. doi:10.1007/s13577-022-00828-9. Epub 2022 Nov 27. PMID: 36436139. [PubMed] (外部リンク)
  15. Amada K, Hijiya N, Ikarimoto S, Yanagihara K, Hanada T, Hidano S, Kurogi S, Tsukamoto Y, Nakada C, Kinoshita K, Hirashita Y, Uchida T, Shin T, Yada K, Hirashita T, Kobayashi T, Murakami K, Inomata M, Shirao K, Aoki M, Takekawa M, Moriyama M. Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor. Cancer Sci. 2023 May;114(5):2189-2202. doi: 10.1111/cas.15735. Epub 2023 Feb 9. PMID: 36694355; PMCID: PMC10154874. [PubMed] (外部リンク)

2022

  1. Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Sugaya J, Kobayashi E, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-PS1-C1: a novel cell line of pleomorphic sarcoma from a patient after neoadjuvant radiotherapy. Hum Cell. 2022 Nov;35(6):2011-2019. doi: 10.1007/s13577-022-00787-1. Epub 2022 Sep 14. PMID: 36103079. [PubMed] (外部リンク)
  2. Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Sato C, Kojima, N, Yoshida A, Kawai A, Ohtori S, Kondo T. Establishment and characterization of NCC-MRT1-C1: a novel cell line of malignant rhabdoid tumor. Hum Cell. 2022 Nov;35(6):2002-2010. doi: 10.1007/s13577-022-00751-z. Epub 2022 Aug 5. Erratum in: Hum Cell. 2023 Jan;36(1):491. doi: 10.1007/s13577-022-00804-3. PMID: 35927606. [PubMed] (外部リンク)
  3. Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Akiyama T, Sato C, Kobayashi E, Kojima N, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-MFS6-C1: a novel patient-derived cell line of myxofibrosarcoma. Hum Cell. 2022 Nov;35(6):1993-2001. doi: 10.1007/s13577-022-00749-7. Epub 2022 Aug 10. PMID: 35947340. [Pubmed] (外部リンク)
  4. Akiyama T, Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Fukushima S, Toda Y, Kojima N, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-GCTB5-C1: a novel cell line of giant cell tumor of bone. Hum Cell. 2022 Sep;35(5):1621-1629. doi: 10.1007/s13577-022-00724-2. Epub 2022 Jun 2. Erratum in: Hum Cell. 2023 Jan;36(1):492. doi: 10.1007/s13577-022-00805-2. PMID: 35653034. [PubMed]（外部リンク）
  5. Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Akiyama T, Sugaya J, Kojima N, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-SS5-C1: a novel patient-derived cell line of synovial sarcoma. Hum Cell. 2022 Jul;35(4):1290-1297. doi: 10.1007/s13577-022-00721-5. Epub 2022 Jun 2. PMID: 35655041. [PubMed]（外部リンク）
  6. Noguchi R, Yoshimatsu Y, Sin Y, Tsuchiya R, Ono T, Akiyama T, Hirabayashi K, Ozawa I, Nakagawa R, Kikuta K, Kondo T. Establishment and characterization of two novel patient-derived myxoid liposarcoma cell lines. Hum Cell. 2022 Jul;35(4):1279-1289. doi: 10.1007/s13577-022-00717-1. Epub 2022 May 30. PMID: 35637403. [PubMed]（外部リンク）
  7. Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Akiyama T, Nakagawa R, Kamio S, Hirabayashi K, Ozawa I, Kikuta K, Kondo T. Establishment and characterization of a novel patient-derived cell line of dedifferentiated liposarcoma, NCC-DDLPS6-C1. Hum Cell. 2022 Jul;35(4):1270-1278. doi: 10.1007/s13577-022-00710-8. Epub 2022 May 23. PMID: 35604485. [PubMed]（外部リンク）
  8. Paudel D, Kuramitsu Y, Uehara O, Morikawa T, Yoshida K, Giri S, Islam ST, Kitagawa T, Kondo T, Sasaki K, Matsuoka H, Miura H, Abiko Y. Proteomic and microbiota analyses of the oral cavity during psychological stress. PLoS One. 2022 May 25;17(5):e0268155. doi: 10.1371/journal.pone.0268155. PMID: 35613108; PMCID: PMC9132284. [PubMed] (外部リンク)
  9. Sin Y, Ono T, Tsuchiya R, Noguchi R, Yoshimatsu Y, Kosako H, Kondo T. Proteomic analysis of spheroids of rhabdomyosarcoma cells cultured with decellularized muscle extracts. J Electrophoresis. 2022:66:1-4. [J-Stage]（外部リンク）
  10. Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Akiyama T, Nakagawa R, Kamio S, Hirabayashi K, Ozawa I, Kikuta K, Kondo T. Establishment and characterization of a novel patient-derived Ewing sarcoma cell line, NCC-ES2-C1. Hum Cell. 2022 Jul;35(4):1262-1269. doi: 10.1007/s13577-022-00701-9. Epub 2022 Apr 19. PMID: 35441357. [PubMed] (外部リンク)
  11. Shirakihara T, Yamaguchi H, Kondo T, Yashiro M, Sakai R. Transferrin receptor 1 promotes the fibroblast growth factor receptor-mediated oncogenic potential of diffused-type gastric cancer. Oncogene. 2022 Apr;41(18):2587-2596. doi: 10.1038/s41388-022-02270-5. Epub 2022 Mar 25. PMID: 35338344. [PubMed]（外部リンク）
  12. Ponce RKM, Thomas NJ, Bui NQ, Kondo T, Okimoto RA. WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma. JCI Insight. 2022 Mar 22;7(6):e152293. doi: 10.1172/jci.insight.152293. PMID: 35315355; PMCID: PMC8986087. [PubMed]（外部リンク）
  13. Sin Y, Yoshimatsu Y, Noguchi R, Tsuchiya R, Ono T, Akiyama T, Iwata S, Sugaya J, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-DDLPS5-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.  Hum Cell. 2022 May;35(3):936-943. doi: 10.1007/s13577-022-00689-2. Epub 2022 Mar 15. PMID: 35292923. [PubMed]（外部リンク）
  14. Noguchi R, Yoshimatsu Y, Sin Y, Ono T, Tsuchiya R, Yoshida A, Kiyono T, Yonemura Y, Kondo T. Establishment and characterization of NCC-PMP1-C1: a novel patient-derived cell line of metastatic pseudomyxoma peritonei.  J Pers Med. 2022 Feb 10;12(2):258. doi: 10.3390/jpm12020258. Erratum in: J Pers Med. 2023 Sep 15;13(9):1383. doi: 10.3390/jpm13091383. PMID: 35207746; PMCID: PMC8877412. [PubMed]（外部リンク）
  15. Ono T, Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Akiyama T, Sugaya J, Fukushima S, Kojima N, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-UPS4-C1: a novel cell line of undifferentiated pleomorphic sarcoma from a patient with Li-Fraumeni syndrome. Hum Cell. 2022 Mar;35(2):756-766. doi: 10.1007/s13577-022-00671-y. Epub 2022 Feb 3. PMID: 35118583. [PubMed]（外部リンク）
  16. Tsuchiya R, Yoshimatsu Y, Noguchi R, Sin Y, Ono T, Akiyama T, Sugaya J, Kobayashi E, Kojima N, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-MFS5-C1: a novel patient-derived cell line of myxofibrosarcoma. Cells. 2022 Jan 8;11(2):207. doi: 10.3390/cells11020207. PMID: 35053323; PMCID: PMC8773631. [PubMed]（外部リンク）
  17. Sin Y, Yoshimatsu Y, Noguchi R, Tsuchiya R, Ono T, Akiyama T, Nakatani F, Sugaya J, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-MPNST6-C1: a novel patient-derived cell line of malignant peripheral nerve sheath tumors. Hum Cell. 2022 Jan;35(1):400-407. doi:10.1007/s13577-021-00643-8. Epub 2021 Nov 14. PMID: 34775549. [PubMed]（外部リンク）
  18. Noguchi R, Yoshimatsu Y, Ono T, Sei A, Motoi N, Yatabe Y, Yoshida Y, Watanabe S, Kondo T. Establishment and characterization of NCC-DMM1-C1, a novel patient-derived cell line of desmoplastic malignant pleural mesothelioma. Oncol Lett. 2022 Feb;23(2):64. doi: 10.3892/ol.2021.13182. Epub 2021 Dec 27. PMID: 35069873; PMCID: PMC8756558. [PubMed]（外部リンク）
  19. Ono T, Noguchi R, Yoshimatsu Y, Tsuchiya R, Sin Y, Nakagawa R, Hirabayashi K, Ozawa I, Kikuta K, Kondo T. Establishment and characterization of the NCC-GCTB4-C1 cell line: a novel patient-derived cell line from giant cell tumor of bone. Hum Cell. 2022 Jan;35(1):392-399. doi: 10.1007/s13577-021-00639-4. Epub 2021 Nov 3. PMID: 34731453. [PubMed]（外部リンク）
  20. Tsuchiya R, Yoshimatsu Y, Noguchi R, Sin Y, Ono T, Akiyama T, Sugaya J, Nakatani F, Kojima N, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma. Hum Cell. 2022 Jan;35(1):384-391. doi:10.1007/s13577-021-00633-w. Epub 2021 Oct 19. PMID: 34665443. [PubMed]（外部リンク）

2021

  1. Tsuchiya R, Yoshimatsu Y, Noguchi R, Sin Y, Ono T, Akiyama T, Hirose T, Iwata S, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-DDLPS4-C1: a novel patient-derived cell line of dedifferentiated liposarcoma.  J Pers Med. 2021 Oct 24;11(11):1075. doi: 10.3390/jpm11111075. PMID: 34834427; PMCID: PMC8618493. [PubMed]（外部リンク）
  2. Ono T, Noguchi R, Yoshimatsu Y, Sin Yooksil, Kojima N, Kondo T. Development of different organ derived decellularized tissue gels that support in vitro tumor cell behavior in a tumor type-specific manner. J Electrophoresis. 2021 65(1): 33-37. [J-Stage]（外部リンク）
  3. Komatsu A, Matsumoto K, Yoshimatsu Y, Sin Y, Kubota A, Saito T, Muzumoto A, Ohashi S, Muto Manabu, Noguchi R, Kondo T, Tamanoi F. The CAM Model for CIC-DUX4 Sarcoma and Its Potential Use for Precision Medicine. Cells. 2021 Oct 1;10(10):2613. doi: 10.3390/cells10102613. PMID: 34685592; PMCID: PMC8533847. [PubMed]（外部リンク）
  4. Yoshimatsu Y, Noguchi R, Sin Y, Tsuchiya R, Ono T, Sei A, Sugaya J, Iwata S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-LGFMS1-C1: a novel patient-derived cell line of low-grade fibromyxoid sarcoma. Hum Cell. 2021 Nov;34(6):1919-1928. doi: 10.1007/s13577-021-00612-1. Epub 2021 Sep 17. PMID: 34535876. [PubMed]（外部リンク）
  5. Yamawaki K, Mori Y, Sakai H, Kanda Y, Shiokawa D, Ueda H, Ishiguro T, Yoshihara K, Nagasaka K, Onda T, Kato T, Kondo T, Enomoto T, Okamoto K. Integrative analyses of gene expression and chemosensitivity of patient-derived ovarian cancer spheroids link G6PD-driven redox metabolism to cisplatin chemoresistance. Cancer Lett. 2021 Aug 19. doi: 10.1016/j.canlet.2021.08.018. Epub ahead of print. PMID: 34419499. [PubMed]（外部リンク）
  6. Yoshimatsu Y, Noguchi R, Tsuchiya R, Sin Y, Ono T, Sugaya J, Iwata S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-MFS4-C1: a novel patient-derived cell line of myxofibrosarcoma. Hum Cell. 2021 Nov;34(6):1911-1918. doi: 10.1007/s13577-021-00589-x. Epub 2021 Aug 12. PMID: 34383271. [PubMed]（外部リンク）
  7. Yoshimatsu Y, Noguchi R, Tsuchiya R, Ono T, Sin Y, Akane S, Sugaya J, Mori T, Fukushima S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of novel patient-derived cell lines from giant cell tumor of bone. Hum Cell. 2021 Nov;34(6):1899-1910. doi: 10.1007/s13577-021-00579-z. Epub 2021 Jul 24. PMID: 34304386. [PubMed]（外部リンク）
  8. DeSalvo J, Ban Y, Li L, Sun X, Jiang Z, Kerr DA, Khanlari M, Boulina M, Capecchi MR, Partanen JM, Chen L, Kondo T, Ornitz DM, Trent JC, Eid JE. ETV4 and ETV5 drive synovial sarcoma through cell cycle and DUX4 embryonic pathway control. J Clin Invest. 2021 Jul 1;131(13):e141908. doi: 10.1172/JCI141908. PMID: 33983905; PMCID: PMC8245179. [PubMed]（外部リンク）
  9. Takamizawa Y, shida D, Horie T, Tsukamoto S, Esaki M, Shimada K, Kondo T, Kanemitsu Y. Prognostic role for primary tumor location in patients with colorectal liver metastases: A comparison of right-sided colon, left-sided colon, and rectum. Dis Colon Rectum. 2023 Feb 1;66(2):233-242. doi: 10.1097/DCR.0000000000002228. Epub 2022 Dec 27. PMID: 35714342. [PubMed]（外部リンク）
  10. Tsuchiya R, Yoshimatsu Y, Noguchi R, Sin Y, Ono T, Sei A, Takeshita F, Sugaya J, Nakatani F, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma. Hum Cell. 2021 Sep;34(5):1569-1578. doi: 10.1007/s13577-021-00569-1. Epub 2021 Jun 23. PMID: 34164773. [PubMed]（外部リンク）
  11. Noguchi R, Yoshimatsu Y, Sei A, Yoshida H, Katou T, Kondo T. Drug screening and kinase activity profiling of a novel patient-derived cell line of clear cell ovarian carcinoma. J Electrophoresis. 2021:65:23-31. [J-Stage]（外部リンク）
  12. Tsuchiya R, Yoshimatsu Y, Noguchi R, Sin Y, Ono T, Sei A, Takeshita F, Sugaya J, Iwata S, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-MFS3-C1: a novel patient-derived cell line of myxofibrosarcoma. Hum Cell. 2021 Jul;34(4):1266-1273. doi: 10.1007/s13577-021-00548-6. Epub 2021 May 15. PMID: 33990915. [PubMed]（外部リンク）
  13. Tsuchiya R, Yoshimatsu Y, Noguchi R, Ono T, Sei A, Takeshita F, Sugaya J, Fukushima S, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-DDLPS3-C1: a novel patient-derived cell line of dedifferentiated liposarcoma. Hum Cell. 2021 May;34(3):1008-1018. doi:10.1007/s13577-021-00515-1. Epub 2021 Mar 6. PMID: 33677797. [PubMed]（外部リンク）
  14. Ozawa T, Kaneko S, Szulzewsky F, Qiao Z, Takadera M, Narita Y, Kondo T, Holland EC, Hamamoto R, Ichimura K. C11orf95-RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation. Acta Neuropathol Commun. 2021 Mar 8;9(1):36. doi: 10.1186/s40478-021-01135-4.PMID: 33685520; PMCID: PMC7941712. [PubMed]（外部リンク）
  15. Tsuchiya R, Yoshimatsu Y, Tsuchiya N, Ohtori S, Kawai A, Kondo T. Comprehensive miRNA expression analysis for histological subtypes of soft tissue sarcoma. J Electrophoresis. 2021: 65: 13-22. doi:https://doi.org/10.2198/jelectroph.65.13 [J-Stage]（外部リンク）
  16. Noguchi R, Yoshimatsu Y, Ono T, Sei A, Kondo T. Proteogenomics approach to drug targets in osteosarcomas with different original sites. J Electrophoresis. 2021 65:1-11. doi:https://doi.org/10.2198/jelectroph.65.1 [J-Stage]（外部リンク）
  17. Noguchi R, Yoshimatsu Y, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T. Establishment and characterization of NCC-MLPS1-C1: a novel patient-derived cell line of myxoid liposarcoma. Hum Cell. 2021 Mar;34(2):667-674. doi: 10.1007/s13577-020-00454-3. Epub 2020 Nov 4. PMID: 33146842. [PubMed]（外部リンク）
  18. Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T. Establishment and characterization of NCC-PLPS1-C1, a novel patient-derived cell line of pleomorphic liposarcoma. Hum Cell. 2021 Mar;34(2):688-697. doi: 10.1007/s13577-020-00457-0. Epub 2020 Nov 17. PMID: 33205363. [PubMed]（外部リンク）
  19. Tsuchiya R, Yoshimatsu Y, Noguchi R, Ono T, Sei A, Takeshita F, Sugaya J, Iwata S, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-SS4-C1: a novel patient-derived cell line of synovial sarcoma. Hum Cell. 2021 May;34(3):998-1007. doi: 10.1007/s13577-021-00509-z. Epub 2021 Feb 20. PMID: 33611700. [PubMed]（外部リンク）
  20. Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T. Establishment and characterization of a novel cell line, NCC-DDLPS2-C1, derived from a patient with dedifferentiated liposarcoma. Hum Cell. 2021 May;34(3):990-997. doi: 10.1007/s13577-021-00497-0. Epub 2021 Feb 8. PMID: 33555519. [PubMed]（外部リンク）
  21. Hirozane T, Masuda M, Sugano T, Sekita T, Goto N, Aoyama T, Sakagami T, Uno Y, Moriyama H, Sawa M, Asano N, Nakamura M, Matsumoto M, Nakayama R, Kondo T, Kawai A, Kobayashi E, Yamada T. Direct conversion of osteosarcoma to adipocytes by targeting TNIK. JCI Insight. 2021 Feb 8;6(3):e137245. doi: 10.1172/jci.insight.137245. PMID: 33400690; PMCID: PMC7934882. [PubMed]（外部リンク）
  22. Hamoya T, Fujii G, Iizumi Y, Narita T, Komiya M, Matsuzawa Y, Miki K, Kondo T, Kishimoto S, Watanabe K, Wakabayashi K, Sakai T, Toshima J, Mutoh M. Artesunate inhibits intestinal tumorigenesis through inhibiting wnt signaling. Carcinogenesis. 2021 Feb 11;42(1):148-158. doi:10.1093/carcin/bgaa084. PMID: 32710739. [PubMed]（外部リンク）
  23. Jimura N, Fujii K, Qiao Z, Tsuchiya R, Yoshimatsu Y, Kondo T, Kanekura T. Kinome profiling analysis identified Src pathway as a novel therapeutic target in combination with histone deacetylase inhibitors for cutaneous T-cell lymphoma. J Dermatol Sci. 2021 Mar;101(3):194-201. doi: 10.1016/j.jdermsci.2021.01.004. Epub 2021 Jan 22. PMID: 33531202. [PubMed]（外部リンク）
  24. Nakano Y, Takadera M, Miyazaki M, Qiao Z, Nakajima K, Noguchi R, Oyama R, Kimura Y, Okuhiro Y, Yamasaki K, Kunihiro N, Fukushima H, Inoue T, Hara J, Ozawa T, Kondo T, Ichimura K. Drug screening with a novel tumor-derived cell line identified alternative therapeutic options for patients with atypical teratoid/rhabdoid tumor. Hum Cell. 2021 Jan;34(1):271-278. doi: 10.1007/s13577-020-00438-3. Epub 2020 Sep 30. PMID: 32997328. [PubMed]（外部リンク）
  25. Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T. Establishment and characterization of NCC-MFS2-C1: a novel patient-derived cancer cell line of myxofibrosarcoma. Hum Cell. 2021 Jan;34(1):246-253. doi: 10.1007/s13577-020-00420-z. Epub 2020 Sep 1. PMID: 32870449. [PubMed]（外部リンク）
  26. Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T. Establishment and characterization of a novel cell line, NCC-TGCT1-C1, derived from a patient with tenosynovial giant cell tumor. Hum Cell. 2021 Jan;34(1):254-259. doi: 10.1007/s13577-020-00425-8. Epub 2020 Sep 4. PMID:32886306. [PubMed]（外部リンク）
  27. Tsuchiya R, Yoshimatsu Y, Noguchi R, Sei A, Takeshita F, Sugaya J, Fukushima S, Yoshida A, Ohtori S, Kawai A, Kondo T. Establishment and characterization of NCC-DDLPS1-C1: a novel patient-derived cell line of dedifferentiated liposarcoma. Hum Cell. 2021 Jan;34(1):260-270. doi: 10.1007/s13577-020-00436-5. Epub 2020 Sep 19. PMID: 32949334. [PubMed]（外部リンク）
  28. Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T. Establishment and characterization of NCC-LMS2-C1-a novel patient- derived cancer cell line of leiomyosarcoma. Hum Cell. 2021 Jan;34(1):279-288. doi: 10.1007/s13577-020-00443-6. Epub 2020 Oct 1. PMID: 33001379. [PubMed]（外部リンク）
  29. Kondo T. Current status and future outlook for patient-derived cancer models from a rare cancer research perspective. Cancer Sci. 2021 Mar;112(3):953-961. doi: 10.1111/cas.14669. Epub 2021 Feb 6. PMID: 32986888; PMCID: PMC7935796. [PubMed]（外部リンク）

2020

  1. Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I, Kikuta K, Kondo T. Establishment and characterization of NCC-GCTB1-C1: a novel patient-derived cancer cell line of giant cell tumor of bone. Hum Cell. 2020 Oct;33(4):1321-1328. doi: 10.1007/s13577-020-00415-w. Epub 2020 Aug 19. PMID:32815117. [PubMed]（外部リンク）
  2. Sin Y, Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Ono T, Toki S, Kobayashi E, Arakawa A, Sugiyama M, Yoshida A, Kawai A, Kondo T. Establishment and characterization of a novel alveolar rhabdomyosarcoma cell line, NCC-aRMS1-C1. Hum Cell. 2020 Oct;33(4):1311-1320. doi: 10.1007/s13577-020-00403-0. Epub 2020 Jul 26. PMID: 32715445. [PubMed]（外部リンク）
  3. Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Sugaya J, Fukushima S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-ASPS1-C1: a novel patient-derived cell line of alveolar soft-part sarcoma. Hum Cell. 2020 Oct;33(4):1302-1310. doi: 10.1007/s13577-020-00382-2. Epub 2020 Jul 10. PMID:32648033. [PubMed]（外部リンク）
  4. Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Nakagawa M, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-DFSP3-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line. Hum Cell. 2020 Jul;33(3):894-903. doi: 10.1007/s13577-020-00365-3. Epub 2020 Apr 30. PMID: 32356243. [PubMed]（外部リンク）
  5. Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Sugaya J, Iwata S, Sugiyama M, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-ssRMS1-C1: a novel patient-derived spindle-cell/sclerosing rhabdomyosarcoma cell line. Hum Cell. 2020 Jul;33(3):886-893. doi: 10.1007/s13577-020-00359-1. Epub 2020 Apr 16. PMID: 32300959. [PubMed]（外部リンク）
  6. Yoshimatsu Y, Noguchi R, Tsuchiya R, Sei A, Sugaya J, Iwata S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of NCC-SS3-C1: a novel patient-derived cell line of synovial sarcoma. Hum Cell. 2020 Jul;33(3):877-885. doi: 10.1007/s13577-020-00354-6. Epub 2020 Apr 9. PMID: 32274656. [PubMed]（外部リンク）
  7. Yoshimatsu Y, Noguchi R, Tsuchiya R, Kito F, Sei A, Sugaya J, Nakagawa M, Yoshida A, Iwata S, Kawai A, Kondo T. Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma. Hum Cell. 2020 Apr;33(2):427-436. doi: 10.1007/s13577-019-00312-x. Epub 2020 Jan 2. PMID:31898195. [PubMed]（外部リンク）
  8. Yasukawa M, Ando Y, Yamashita T, Matsuda Y, Shoji S, Morioka MS, Kawaji H, Shiozawa K, Machitani M, Abe T, Yamada S, Kaneko MK, Kato Y, Furuta Y, Kondo T, Shirouzu M, Hayashizaki Y, Kaneko S, Masutomi K. CDK1 dependent phosphorylation of hTERT contributes to cancer progression. Nat Commun. 2020 Mar 25;11(1):1557. doi: 10.1038/s41467-020-15289-7. PubMed PMID: 32214089; PubMed Central PMCID: PMC7096428. [PubMed]（外部リンク）
  9. Oyama R, Kito F, Takahashi M, Hattori E, Noguchi R, Takai Y, Sakumoto M, Qiao Z, Toki S, Sugawara M, Tanzawa Y, Kobayashi E, Nakatani F, Iwata S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors. Cancer Cell Int. 2020 Feb 19. doi: 10.1186/s12935-020-1128-z. PMID: 32099531; PMCID: PMC7031935. [PubMed]（外部リンク）
  10. Kito F, Oyama R, Noguchi R, Hattori E, Sakumoto M, Endo M, Kobayashi E, Yoshida A, Kawai A, Kondo T. Establishment and characterization of novel patient-derived extraskeletal osteosarcoma cell line NCC-ESOS1-C1. Hum Cell. 2020 Jan;33(1):283-290. doi: 10.1007/s13577-019-00291-z. Epub 2019 Oct 17. PMID:31625124. [PubMed]（外部リンク）
  11. Noguchi R, Sin Y, Kondo T. Gel electrophoresis for phosphorylated proteins: a brief introduction. J Electrophoresis. J Electrophoresis. 2020 64(1):13-17. [PubMed]（外部リンク）
  12. Kondo T. Current status and future outlook for patient-derived cancer models from a rare cancer research perspective. Cancer Sci. 2021 Mar;112(3):953-961. doi: 10.1111/cas.14669. Epub 2021 Feb 6. PMID: 32986888; PMCID: PMC7935796. [PubMed]（外部リンク）
  13. Kondo T. Current status and perspectives of patient-derived rare cancer models. Hum Cell. 2020 Oct;33(4):919-929. doi: 10.1007/s13577-020-00391-1. Epub 2020 Jun 14. PMID: 32537685. [PubMed]（外部リンク）
  14. Kondo T. Necessity of guidelines for publication of patient-derived cancer models. Ann Transl Med. 2020 Mar;8(5):158. doi: 10.21037/atm.2019.12.144. PMID:32309306; PMCID: PMC7154464. [PubMed]（外部リンク）

2019

  1. Asano N, Takeshima H, Yamashita S, Takamatsu H, Hattori N, Kubo T, Yoshida A, Kobayashi E, Nakayama R, Matsumoto M, Nakamura M, Ichikawa H, Kawai A, Kondo T, Ushijima T. Epigenetic reprogramming underlies efficacy of DNA demethylation therapy in osteosarcomas. Sci Rep. 2019 Dec 30;9(1):20360. doi:10.1038/s41598-019-56883-0. PubMed PMID: 31889115. [PubMed]（外部リンク）
  2. Hirata M, Asano N, Katayama K, Yoshida A, Tsuda Y, Sekimizu M, Mitani S, Kobayashi E, Komiyama M, Fujimoto H, Goto T, Iwamoto Y, Naka N, Iwata S, Nishida Y, Hiruma T, Hiraga H, Kawano H, Motoi T, Oda Y, Matsubara D, Fujita M, Shibata T, Nakagawa H, Nakayama R, Kondo T, Imoto S, Miyano S, Kawai A, Yamaguchi R, Ichikawa H, Matsuda K. Integrated exome and RNA sequencing of dedifferentiated liposarcoma. Nat Commun. 2019 Dec 12;10(1):5683 . doi: 10.1038/s41467-019-13286-z. PubMed PMID: 31831742. [PubMed]（外部リンク）
  3. Shiozawa K, Oyama R, Takahashi M, Kito F, Hattori E, Yoshida A, Kawai A, Ono M, Kondo T. Species-Specific Quantitative Proteomics Profiles of Sarcoma Patient-Derived Models Closely Reflect Their Primary Tumors. Proteomics Clin Appl. 2019 Nov;13(6):e1900054. doi: 10.1002/prca.201900054. Epub 2019 Sep 4. PMID: 31419061. [PubMed]（外部リンク）
  4. Okimoto RA, Wu W, Nanjo S, Olivas V, Lin YK, Ponce RK, Oyama R, Kondo T, Bivona TG. CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs. J Clin Invest. 2019 Jul 22;129(8):3401-3406. doi:10.1172/JCI126366. eCollection 2019 Jul 22. PubMed PMID: 31329165; PubMed Central PMCID: PMC6668665. [PubMed]（外部リンク）
  5. Jia X, Chen C, Chen L, Yu C, Kondo T. Decorin as a prognostic biomarker in patients with malignant peripheral nerve sheath tumors. Oncol Lett. 2019 Mar;17(3):3517-3522. doi: 10.3892/ol.2019.9959. Epub 2019 Jan 23. PubMed PMID: 30867792; PubMed Central PMCID: PMC6396138. [PubMed]（外部リンク）
  6. Tajima T, Kito F, Yoshida A, Kawai A, Kondo T. Calreticulin as A Novel Potential Metastasis-Associated Protein in Myxoid Liposarcoma, as Revealed by Two-Dimensional Difference Gel Electrophoresis. Proteomes. 2019 Apr 10;7(2). pii: E13. doi: 10.3390/proteomes7020013. PubMed PMID: 30974841. [PubMed]（外部リンク）
  7. Asano N, Matsuzaki J, Ichikawa M, Kawauchi J, Takizawa S, Aoki Y, Sakamoto H, Yoshida A, Kobayashi E, Tanzawa Y, Nakayama R, Morioka H, Matsumoto M, Nakamura　M, Kondo T, Kato K, Tsuchiya N, Kawai A, Ochiya T. A serum microRNA classifier　for the diagnosis of sarcomas of various histological subtypes. Nat Commun. 2019 Mar 21;10(1):1299. doi: 10.1038/s41467-019-09143-8. PubMed PMID: 30898996 [PubMed]（外部リンク）
  8. Kito F, Oyama R, Sakumoto M, Shiozawa K, Qiao Z, Toki S, Yoshida A, Kawai A, Kondo T. Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma. Hum Cell. 2019 Apr;32(2):214-222. doi: 10.1007/s13577-018-00233-1. Epub 2019 Feb 8. PubMed PMID: 30737712. [PubMed]（外部リンク）
  9. Oyama R, Kito F, Takahashi M, Sakumoto M, Shiozawa K, Qiao Z, Noguchi R, Kubo T, Toki S, Nakatani F, Yoshida A, Kawai A, Kondo T. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1. Hum Cell. 2019 Apr;32(2):202-213. doi: 10.1007/s13577-018-00232-2. PubMed PMID: 30737713. [PubMed]（外部リンク）
  10. Oyama R, Takahashi M, Kito F, Sakumoto M, Takai Y, Kumiko S, Qiao Z, Toki S, Tanzawa Y, Yoshida A, Kawai A, Kondo T. Establishment and characterization of patient-derived pleomorphic rhabdomyosarcoma models. Tiss. Cult. Res. Commun. 2019;38(1)1-12. [J-Stage]（外部リンク）
  11. Qiao Z, Kondo T. Screening of a growth inhibitor library of sarcoma cell lines to identify potent anti-cancer drugs.J Electrophoresis. 2019 63:1-7. [J-Stage]（外部リンク）
  12. Qiao Z, Kondo T. Identification of cantharidin as a drug candidate for glioblastoma by using a Connectivity Map-based approach. J Electrophoresis. 2019 63:9-14. [J-Stage]（外部リンク）
  13. Patel N, Wang J, Shiozawa K, Jones KB, Zhang Y, Prokop JW, Davenport GG, Nihira NT, Hao Z, Wong D, Brandsmeier L, Meadows SK, Sampaio AV, Werff RV, Endo M, Capecchi MR, McNagny KM, Mak TW, Nielsen TO, Underhill TM, Myers RM, Kondo T, Su L. HDAC2 Regulates Site-Specific Acetylation of MDM2 and Its Ubiquitination Signaling in Tumor Suppression. iScience. 2019 Mar 29. doi:10.1016/j.isci.2019.02.008. Epub 2019 Feb 15. PubMed PMID: 30818224; PubMed Central PMCID: PMC6393697. [PubMed]（外部リンク）
  14. Hattori E, Oyama R, Kondo T. Systematic Review of the Current Status of Human Sarcoma Cell Lines. Cells. 2019 Feb 13;8(2). pii: E157. doi: 10.3390/cells8020157. PubMed PMID: 30781855; PubMed Central PMCID: PMC6406745.  [PubMed]（外部リンク）
  15. Oyama R, Kito F, Qiao Z, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T. Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1. In Vitro Cell Dev Biol Anim. 2019 Jan;55(1):62-73. doi: 10.1007/s11626-018-0305-z. PubMed PMID: 30411273. [PubMed]（外部リンク）
  16. Hattori E, Kondo T. Current status of cancer proteogenomics: a brief introduction. J Electrophoresis. 2019 63:33-37. [J-Stage]（外部リンク）
  17. Kondo T. Cancer biomarker development and two-dimensional difference gel electrophoresis (2D-DIGE). Biochim Biophys Acta Proteins Proteom. 2019 Jan;1867(1):2-8. doi: 10.1016/j.bbapap.2018.07.002. Epub 2018 Jul 7. Review. PubMed PMID: 30392560. [PubMed]（外部リンク）

2018

  1. Qiao Z, Parlayan C, Saito S, Kondo T. Meta-analysis of global gene-expression profiles identify molecular signatures for histological subtypes of sarcomas. J Electrophoresis. 2018 62:21-29. [J-Stage]（外部リンク）
  2. Shiozawa K, Yoshioka Y, Qiao Z, Shuting J, Ochiya T, Kondo T. Pazopanib-induced changes in protein expression signatures of extracellular vesicles in synovial sarcoma. Biochem Biophys Res Commun. 2018 Nov 30;506(3):723-730. doi: 10.1016/j.bbrc.2018.10.012. Epub 2018 Oct 27. PubMed PMID: 30454707. [PubMed]（外部リンク）
  3. Oyama R, Kito F, Qiao Z, Sakumoto M, Noguchi R, Takahashi M, Toki S, Tanzawa Y, Yoshida A, Kawai A, Kondo T. Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1. In Vitro Cell Dev Biol Anim. 2018 Dec;54(10):770-778. doi: 10.1007/s11626-018-0302-2. Epub 2018 Oct 15. PubMed PMID: 30324244. [PubMed]（外部リンク）
  4. Qiao Z, Kondo T. Identification of cephalomannine as a drug candidate for glioblastoma via high-throughput drug screening. J Electrophoresis 2018;62:17. [J-Stage]（外部リンク）
  5. Kito F, Oyama R, Sakumoto M, Takahashi M, Shiozawa K, Qiao Z, Sakamoto H, Hirose T, Setsu N, Yoshida A, Kawai A, Kondo T. Establishment and characterization of novel patient-derived osteosarcoma xenograft and cell line. In Vitro Cell Dev Biol Anim. 2018 Aug;54(7):528-536. doi: 10.1007/s11626-018-0274-2. Epub 2018 Jun 25. PubMed PMID: 29943355. [PubMed]（外部リンク）
  6. Kito F, Oyama R, Takahashi M, Shiozawa K, Sakumoto M, Yoshida A, Setsu N, Kobayashi E, Kawai A, Kondo T. Establishment and characterization of a patient-derived cancer model of undifferentiated pleomorphic sarcoma. Tiss. Cult. Res. Commun. 2018 37: 1–13 [J-Stage]（外部リンク）
  7. Oyama R, Takahashi M, Kito F, Sakumoto M, Shiozawa K, Qiao Z, Yoshida A, Endo M, Kawai A, Kondo T. Establishment and characterization of patient-derived xenograft and its cell line of primary leiomyosarcoma of bone. In Vitro Cell Dev Biol Anim. 2018 Jun;54(6):458-467. doi: 10.1007/s11626-018-0258-2. Epub 2018 May 29. PubMed PMID: 29845452. [PubMed]（外部リンク）
  8. Kito F, Oyama R, Takai Y, Sakumoto M, Shiozawa K, Qiao Z, Uehara T, Yoshida A, Kawai A, Kondo T. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line. Hum Cell. 2018 Apr;31(2):167-174. doi: 10.1007/s13577-018-0199-9. Epub 2018 Feb 15. PubMed PMID: 29450702. [PubMed]（外部リンク）
  9. Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Endo M, Yoshida A, Kawai A, Kondo T. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. In Vitro Cell Dev Biol Anim. 2018 May;54(5):392-399. doi:10.1007/s11626-018-0237-7. Epub 2018 Apr 6. PubMed PMID: 29626278. [PubMed]（外部リンク）
  10. Fujii K, Suzuki N, Jimura N, Idogawa M, Kondo T, Iwatsuki K, Kanekura T. HSP72 functionally inhibits the anti-neoplastic effects of HDAC inhibitors. J Dermatol Sci. 2018 Apr;90(1):82-89. doi: 10.1016/j.jdermsci.2018.01.002. Epub 2018 Jan 31. PubMed PMID: 29395577. [PubMed]（外部リンク）
  11. Oyama R, Kito F, Sakumoto M, Shiozawa K, Toki S, Yoshida A, Kawai A, Kondo T.  Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1, derived from a patient with undifferentiated pleomorphic sarcoma. In Vitro Cell Dev Biol Anim. 2018 Mar;54(3):257-263. doi: 10.1007/s11626-018-0229-7. Epub 2018 Jan 22. PubMed PMID: 29359268. [PubMed]（外部リンク）
  12. Sakumoto M, Oyama R, Takahashi M, Takai Y, Kito F, Shiozawa K, Qiao Z, Endo M, Yoshida A, Kawai A, Kondo T. Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines. In Vitro Cell Dev Biol Anim. 2018 Feb;54(2):163-176. doi: 10.1007/s11626-017-0207-5. Epub 2017 Dec 1. PubMed PMID: 29197033. [PubMed]（外部リンク）
  13. Shiozawa K, Shuting J, Yoshioka Y, Ochiya T, Kondo T. Extracellular vesicle-encapsulated microRNA-761 enhances pazopanib resistance in synovial sarcoma. Biochem Biophys Res Commun. 2018 Jan 1;495(1):1322-1327. doi: 10.1016/j.bbrc.2017.11.164. Epub 2017 Nov 27. PMID: 29191657. [PubMed]（外部リンク）
  14. Kondo T. Mass Spectrometry and Proteomics 2018: the Mass Spectrometry Society of Japan, Japanese Proteomics Society, and Asia-Oceania Human Proteome Organization. Expert Rev Proteomics. 2018 Oct;15(10):777-779. doi:10.1080/14789450.2018.1525297. Epub 2018 Sep 21. PMID: 30223682. [PubMed]（外部リンク）
  15. Kondo T. Current Status of Proteomics in Ewing's Sarcoma. Proteomics Clin Appl. 2019 May;13(3):e1700130. doi: 10.1002/prca.201700130. Epub 2018 Aug 23. Review. PubMed PMID: 29992772. [PubMed]（外部リンク）

2017

  1. Takai Y, Oyama R, Kito F, Sakumoto M, Shiozawa K, Qiao Z, Nakajima K, Takahashi M, Yoshida A, Setsu N, Kobayashi E, Kawai A, Kondo T. Establishment and characterization of cell line of undifferentiated pleomorphic sarcoma. Tiss Cult Res Comm.2017;36(5)41-48. [J-Stage]（外部リンク）
  2. Qiao Z, Shiozawa K, Kondo T. Proteomic approach toward determining the molecular background of pazopanib resistance in synovial sarcoma. Oncotarget. 2017 Nov 28;8(65):109587-109595. doi: 10.18632/oncotarget.22730. eCollection 2017 Dec 12. PubMed PMID: 29312631; PubMed Central PMCID: PMC5752544. [PubMed]（外部リンク）
  3. Jia X, Chen C, Chen L, Yu C, Kondo T. Large malignant granular cell tumor with suprascapular nerve and brachial plexus invasion: A case report and literature review. Medicine (Baltimore). 2017 Nov;96(44):e8531. doi: 10.1097/MD.0000000000008531. PMID: 29095317; PMCID: PMC5682836. [PubMed]（外部リンク）
  4. Qiao Z, Kito F, Kondo T. Meta-analysis identifies endothelin-3 as a prognostic biomarker in gastrointestinal stromal tumors. J Sarcoma Res [Semantic Scholar]（外部リンク）
  5. Qiao Z, Tajim T, Kito F, Arai Y, Kawai A, Kondo T. Metastasis-associated gene signature in primary myxoid liposarcoma identified through a gene expression study. J Electrophoresis. 2017 61(1):9-15. [J-Stage]（外部リンク）
  6. Qiao Z, Kito F, Takai Y, Oyama R, Kondo T. Secretomics identifies follistatin as a predictive biomarker for response to treatment with tyrosine kinase inhibitors in synovial sarcoma. J Electrophoresis. 2017 61(1):1-7. [J-Stage]（外部リンク）
  7. Sakumoto M, Takahashi M, Oyama R, Takai Y, Kito F, Shiozawa K, Qiao Z, Yoshida A, Endo M, Kawai A, Kondo T. Establishment and proteomic characterization of NCC-LMS1-C1, a novel cell line of primary leiomyosarcoma of the bone. Jpn J Clin Oncol. 2017 Oct 1;47(10):954-961. doi: 10.1093/jjco/hyx096. PubMed PMID:28981730. [PubMed]（外部リンク）
  8. Kikuta K, Kubota D, Yoshida A, Qiao Z, Morioka H, Nakamura M, Matsumoto M, Chuman H, Kawai A, Kondo T. Discoidin, CUB and LCCL domain-containing protein 2 (DCBLD2) is a novel biomarker of myxofibrosarcoma invasion identified by global protein expression profiling. Biochim Biophys Acta Proteins Proteom. 2017 Sep;1865(9):1160-1166. doi: 10.1016/j.bbapap.2017.06.023. Epub 2017 Jun 29. PubMed PMID: 28668639. [PubMed]（外部リンク）
  9. Oyama R, Takahashi M, Yoshida A, Sakumoto M, Takai Y, Kito F, Shiozawa K, Qiao Z, Arai Y, Shibata T, Araki Y, Endo M, Kawai A, Kondo T. Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell lines. Sci Rep. 2017 Jul 5;7(1):4712. doi: 10.1038/s41598-017-04967-0. PubMed PMID: 28680140; PubMed Central PMCID: PMC5498486. [PubMed]（外部リンク）
  10. Nakasuji T, Ogonuki N, Chiba T, Kato T, Shiozawa K, Yamatoya K, Tanaka H, Kondo T, Miyado K, Miyasaka N, Kubota T, Ogura A, Asahara H. Complementary Critical Functions of Zfy1 and Zfy2 in Mouse Spermatogenesis and Reproduction.  PLoS Genet. 2017 Jan 23;13(1):e1006578. doi: 10.1371/journal.pgen.1006578. PMID: 28114340; PMCID: PMC5287576. [PubMed]（外部リンク）
  11. Asano N, Yoshida A, Mitani S, Kobayashi E, Shiotani B, Komiyama M, Fujimoto H, Chuman H, Morioka H, Matsumoto M, Nakamura M, Kubo T, Kato M, Kohno T, Kawai A, Kondo T, Ichikawa H. Frequent amplification of receptor tyrosine kinase genes in welldifferentiated/ dedifferentiated liposarcoma. Oncotarget. 2017 Feb 21;8(8):12941-12952. doi: 10.18632/oncotarget.14652. PMID: 28099935; PMCID: PMC5355068. [PubMed]（外部リンク）
  12. Kondo T. Omics approach for identifying predictive biomarkers in osteosarcoma. Osteosarcoma – Biology, Behavior and Mechanisms. InTech, 2017, DOI:10.5772/67449 [Semantic Scholar]（外部リンク）

2016

  1. Kubota D, Kosaka N, Fujiwara T, Yoshida A, Arai Y, Qiao Z, Takeshita F, Ochiya T, Kawai A, Kondo T. miR-125b and miR-100 Are Predictive Biomarkers of Response to Induction Chemotherapy in Osteosarcoma.  Sarcoma. 2016;2016時13分90571. doi: 10.1155/2016/1390571. Epub 2016 Nov 21. PMID: 27990096; PMCID: PMC5136640. [PubMed]（外部リンク）
  2. Yamasaki H, Miyamoto M, Yamamoto Y, Kondo T, Watanabe T, Ohta T. Synovial sarcoma cell lines showed reduced DNA repair activity and sensitivity to a PARP inhibitor. Genes Cells. 2016 Aug;21(8):852-60. doi: 10.1111/gtc.12387. Epub 2016 Jun 28. PMID: 27353471. [PubMed]（外部リンク）
  3. Qiao Z, Pan X, Parlayan C, Ojima H, Kondo T. Proteomic study of hepatocellular carcinoma using a novel modified aptamer-based array (SOMAscan™) platform. Biochim Biophys Acta. 2017 Apr;1865(4):434-443. doi:10.1016/j.bbapap.2016.09.011. Epub 2016 Sep 20. PubMed PMID: 27663888. [PubMed]（外部リンク）
  4. Jia X, Yang J, Chen L, Yu C, Kondo T. Primary Brachial Plexus Tumors: Clinical Experiences of 143 Cases. Clin Neurol Neurosurg. 2016 Sep;148:91-5. doi: 10.1016/j.clineuro.2016.07.009. Epub 2016 Jul 4. PMID: 27428490. [PubMed]（外部リンク）
  5. Ezawa I, Sawai Y, Kawase T, Okabe A, Tsutsumi S, Ichikawa H, Kobayashi Y,　Tashiro F, Namiki H, Kondo T, Semba K, Aburatani H, Taya Y, Nakagama H, Ohki R.　Novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cells. Cancer Sci. 2016 Jun;107(6):734-45. doi: 10.1111/cas.12933. Epub 2016 May 16. PMID: 26998741; PMCID: PMC4968591. [PubMed]（外部リンク）
  6. Morofuji N, Ojima H, Hiraoka N, Okusaka T, Esaki M, Nara S, Shimada K, Kishi Y, Kondo T. Antibody-based proteomics to identify an apoptosis signature for early recurrence of hepatocellular carcinoma. Clin Proteomics. 2016 Oct 24. eCollection 2016. PubMed PMID: 27799868; PubMed Central PMCID: PMC5078925. [PubMed]（外部リンク）
  7. Asano Y, Kawase T, Okabe A, Tsutsumi S, Ichikawa H, Tatebe S, Kitabayashi I, Tashiro F, Namiki H, Kondo T, Semba K, Aburatani H, Taya Y, Nakagama H, Ohki R. IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis. Sci Rep. 2016 Jan 12;6時19分174. doi: 10.1038/srep19174. PMID: 26754925; PMCID: PMC4709660. [PubMed]（外部リンク）
  8. Takai Y, Matsuo A, Qiao Z, Kondo T. Antitumor activities of BIBF 1120, BI860585, and BI 836845 un preclinical models of sarcoma. Integr Mol Med. 2016 3(4): 755-760, 2016. [Semantic Scholar]（外部リンク）
  9. Pan X, Yoshida A, Kawai A, Kondo T. Current status of publicly available sarcoma cell lines for use in proteomic studies. Expert Rev Proteomics. 2016;13(2):227-40. doi: 10.1586/14789450.2016.1132166. Epub 2016 Jan 11. Review. PMID: 26653594. [PubMed]（外部リンク）
  10. Uemura N, Kondo T. Current status of proteomics of esophageal carcinoma. Expert Rev Proteomics. 2016 Nov;13(11):1029-1040. doi: 10.1080/14789450.2016.1242418. Epub 2016 Oct 8. PubMed PMID: 27678273. [PubMed]（外部リンク）
  11. Kondo T. Proteogenomics for the Study of Gastrointestinal Stromal Tumors. Adv Exp Med Biol. 2016;926:139-151. doi: 10.1007/978-3-319-42316-6_9. PMID: 27686810. [PubMed]（外部リンク）

2015

  1. Tajima T, Kito F, Ohta T, Kawai A, Kondo T. Interactome approach to SBP-1 binding protein in lung adenocarcinoma. J Electrophoresis, 59:1-6, 2015. [J-Stage]（外部リンク）
  2. Ichikawa H, Yoshida A, Kanda T, Kosugi S, Ishikawa T, Hanyu T, Taguchi T, Sakumoto M, Katai H, Kawai A, Wakai T, Kondo T. Prognostic significance of promyelocytic leukemia expression in gastrointestinal stromal tumor; integrated proteomic and transcriptomic analysis. Cancer Sci. 2015 Jan;106(1):115-24. doi: 10.1111/cas.12565. Epub 2014 Dec 4. PMID: 25457157; PMCID: PMC4317774. [PubMed]（外部リンク）
  3. Kikuta K, Morioka H, Kawai A, Kondo T. Global protein-expression profiling for reclassification of malignant fibrous histiocytoma. Biochim Biophys Acta. 2015 Jun;1854(6):696-701. doi: 10.1016/j.bbapap.2014.08.012. Epub 2014 Aug 28.Review. PMID: 25173742. [PubMed]（外部リンク）
  4. Uemura N, Kondo T. Current advances in esophageal cancer proteomics. Biochim Biophys Acta. 2015 Jun;1854(6):687-95. doi: 10.1016/j.bbapap.2014.09.011. Epub 2014 Sep 16.Review. PMID: 25233958. [PubMed]（外部リンク）
  5. Kondo T. Novel prognostic biomarker, pfetin, in gastrointestinal stromal tumors: proteomics study. General Methods in Biomarker Research and Their Applications. Vol. 1, pp251-266, Series Editor: Victor R. Preedy, Springer, ISBN 2015;978-94-007-7695-1. [Springer]（外部リンク）

2014

  1. Taoka M, Morofuji N, Yamauchi Y, Ojima H, Kubota D, Terukina G, Nobe Y, Nakayama H, Takahashi N, Kosuge T, Isobe T, Kondo T. Global PROTOMAP profiling to search for biomarkers of early-recurrent hepatocellular carcinoma. J Proteome Res. 2014 Nov 7;13(11):4847-58. doi: 10.1021/pr500262p. Epub 2014 Jul 7. PubMed PMID: 24967658. [PubMed]（外部リンク）
  2. Hosoya N, Sakumoto M, TomitaY, Kondo T. Approach to spot overlapping problem in　2D-PAGE revealed clinical and functional significance of RKIP and MnSOD in renal cell carcinoma. EuPA Open Proteomics 2014 4: 129-139. [ScienceDirect]（外部リンク）
  3. MukaiharaK, Kubota D, Yoshida A, Kawai A, Kondo T. Proteomic profile of epitheliod sarcoma. J Proteomics Bioinform 2014, 158-165. [LongDom]（外部リンク）
  4. Ito M, Hagiyama M, Mimae T, Inoue T, Kato T, Yoneshige A, Nakanishi J, Kondo T, Okada M, Ito A. α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma. Breast Cancer Res Treat. 2014 Feb;144(1):59-69. doi: 10.1007/s10549-014-2859-0. Epub 2014 Feb 5. PMID: 24496929. [PubMed]（外部リンク）
  5. Fujiwara T, Katsuda T, Hagiwara K, Kosaka N, Yoshioka Y, Takahashi RU, Takeshita F, Kubota D, Kondo T, Ichikawa H, Yoshida A, Kobayashi E, Kawai A, Ozaki T, Ochiya T. Clinical relevance and therapeutic significance of microRNA-133a expression profiles and functions in malignant osteosarcoma-initiating cells. Stem Cells. 2014 Apr;32(4):959-73. doi: 10.1002/stem.1618. PMID: 24715690. [PubMed]（外部リンク）
  6. Kubota D, Yoshida A, Kawai A, Kondo T. Proteomics identified overexpression of SET oncogene product and possible therapeutic utility of protein phosphatase 2A in alveolar soft part sarcoma. J Proteome Res. 2014 May 2;13(5):2250-61. doi: 10.1021/pr400929h. Epub 2014 Mar 31. PubMed PMID: 24621013. [PubMed]（外部リンク）
  7. Mimae T, Ito A, Hagiyama M, Nakanishi J, Hosokawa Y, Okada M, Murakami Y, Kondo T. A novel approach to pseudopodia proteomics: excimer laser etching, two-dimensional difference gel electrophoresis, and confocal imaging. Protoc exch. 2014 Mar 4;2014. pii: 2014.007. [Semantic Scholar]（外部リンク）
  8. Kubota D, Yoshida A, Kikuta K, Saito T, Suehara Y, Gotoh M, Kawai A, Kondo T. Proteomic approach to gastrointestinal stromal tumor identified prognostic biomarkers. J Proteomics Bioinform 2014, 10-16. [LongDom]（外部リンク）
  9. Ichikawa H, Kanda T, Kosugi S, Kawachi Y, Wakai T, Kondo T. Proteomic and meta-transcriptomic study on lymph node metastasis in gastric cancer. EuPA Open proteomics. 2014. [ScienceDirect]（外部リンク）
  10. Tani Y, Tajima T, Kawai A, Unuma Y, Kinoshita H, Kondo T. Evaluation of a Novel Automated Machine, the Auto2D, for Two-Dimensional Gel Electrophoresis. J Proteomics Bioinform. 2014, 7(5):108-111. doi: 10.4172/jpb.1000310. [LongDom]（外部リンク）
  11. Uemura N, Kondo T. Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer. World J Gastrointest Pathophysiol. 2014 Aug 15;5(3):322-34. doi: 10.4291/wjgp.v5.i3.322. Review. PMID: 25133032; PMCID: PMC4133529.  [PubMed]（外部リンク）
  12. Kondo T. Inconvenient truth: cancer biomarker development by using proteomics. Biochim Biophys Acta. 2014 May;1844(5):861-5. doi: 10.1016/j.bbapap.2013.07.009. Epub 2013 Jul 27. PMID: 23896458. [PubMed]（外部リンク）
  13. Kondo T. Casting doubt on the traditional approach of cancer biomarker discovery through proteomics. Expert Rev Proteomics. 2014 Feb;11(1):9-12. doi: 10.1586/14789450.2014.871496. Epub 2013 Dec 18. PMID: 24351084. [PubMed]（外部リンク）

2013

  1. Hosoya N, Sakumoto M, Nakamura Y, Narisawa T, Bilim V, Motoyama T, Tomita Y, Kondo T. Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma. Biochim Biophys Acta. 2013 Dec;1834(12):2630-9. doi:10.1016/j.bbapap.2013.08.009. Epub 2013 Aug 30. PubMed PMID: 23999030. [PubMed]（外部リンク）
  2. Kubota D, Yoshida A, Tsuda H, Suehara Y, Okubo T, Saito T, Orita H, Sato K, Taguchi T, Yao T, Kaneko K, Katai H, Kawai A, Kondo T. Gene expression network analysis of ETV1 reveals KCTD10 as a novel prognostic biomarker in gastrointestinal stromal tumor. PLoS One. 2013 Aug 19;8(8):e73896. doi: 10.1371/journal.pone.0073896. eCollection 2013. PubMed PMID: 23977394; PubMed Central PMCID: PMC3747077. [PubMed]（外部リンク）
  3. Kubota D, Mukaihara K, Yoshida A, Tsuda H, Kawai A, Kondo T. Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcoma. J Proteomics. 2013 Oct 8;91:393-404. doi: 10.1016/j.jprot.2013.07.022. Epub 2013 Aug 2. PubMed PMID: 23911960. [PubMed]（外部リンク）
  4. Ichikawa H, Kanda T, Kosugi S, Kawachi Y, Sasaki H, Wakai T, Kondo T. Laser microdissection and two-dimensional difference gel electrophoresis reveal the role of a novel macrophage-capping protein in lymph node metastasis in gastric cancer. J Proteome Res. 2013 Aug 2;12(8):3780-91. doi: 10.1021/pr400439m. Epub 2013 Jul 9. PubMed PMID: 23782053. [PubMed]（外部リンク）
  5. Yonemori H, Kubota D, Taniguchi H, Tsuda H, Fujita S, Murakami Y, Kondo T. Laser microdissection and two-dimensional difference gel electrophoresis with alkaline isoelectric point immobiline gel reveals proteomic intra-tumor heterogeneity in colorectal cancer. EuPA Open Proteomics. 2013. [ScienceDirect]（外部リンク）
  6. Arai K, Sakamoto R, Kubota D, Kondo T. Proteomic approach toward molecular backgrounds of drug resistance of osteosarcoma cells in spheroid culture system. Proteomics. 2013 Aug;13(15):2351-60. doi: 10.1002/pmic.201300053. Epub 2013 Jun 28. PubMed PMID: 23712969. [PubMed]（外部リンク）
  7. Kubota D, Mukaihara K, Yoshida A, Suehara Y, Saito T, Okubo T, Gotoh M, Orita H, Tsuda H, Kaneko K, Kawai A, Kondo T, Sato K, Yao T. The prognostic value of pfetin: a validation study in gastrointestinal stromal tumors using a commercially available antibody. Jpn J Clin Oncol. 2013 Jun;43(6):669-75. doi: 10.1093/jjco/hyt057. Epub 2013 Apr 25. PubMed PMID: 23619989. [PubMed]（外部リンク）
  8. Kimura K, Ojima H, Kubota D, Sakumoto M, Nakamura Y, Tomonaga T, Kosuge T, Kondo T. Proteomic identification of the macrophage-capping protein as a protein contributing to the malignant features of hepatocellular carcinoma. J Proteomics. 2013 Jan 14;78:362-73. doi: 10.1016/j.jprot.2012.10.004. Epub 2012 Oct 17. PubMed PMID: 23085225. [PubMed]（外部リンク）
  9. Huang C, Wang Y, Liu S, Ding G, Liu W, Zhou J, Kuang M, Ji Y, Kondo T, Fan J. Quantitative proteomic analysis identified paraoxonase 1 as a novel serum biomarker for microvascular invasion in hepatocellular carcinoma. J Proteome Res. 2013 Apr 5;12(4):1838-46. doi: 10.1021/pr3011815. Epub 2013 Mar 5. PubMed PMID:23442176. [PubMed]（外部リンク）
  10. Haga A, Ogawara Y, Kubota D, Kitabayashi I, Murakami Y, Kondo T. Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma. Electrophoresis. 2013 Jun;34(11):1670-8. doi: 10.1002/elps.201200661. PubMed PMID: 23483572. [PubMed]（外部リンク）
  11. Yamamoto T, Nakayama K, Hirano H, Tomonaga T, Ishihama Y, Yamada T, Kondo T, Kodera Y, Sato Y, Araki N, Mamitsuka H, Goshima N. Integrated view of the human chromosome X-centric proteome project. J Proteome Res. 2013 Jan 4;12(1):58-61. doi: 10.1021/pr300844p. Epub 2012 Dec 21. PubMed PMID: 23259409. [PubMed]（外部リンク）
  12. Sugihara Y, Taniguchi H, Kushima R, Tsuda H, Kubota D, Ichikawa H, Fujita S, Kondo T. Laser microdissection and two-dimensional difference gel electrophoresis reveal proteomic intra-tumor heterogeneity in colorectal cancer. J Proteomics. 2013 Jan 14;78:134-47. doi: 10.1016/j.jprot.2012.11.009. Epub 2012 Nov 23. PubMed PMID: 23178874. [PubMed]（外部リンク）
  13. Hasegawa T, Asanuma H, Ogino J, Hirohashi Y, Shinomura Y, Iwaki H, Kikuchi H, Kondo T. Use of potassium channel tetramerization domain-containing 12 as a biomarker for diagnosis and prognosis of gastrointestinal stromal tumor. Hum Pathol. 2013 Jul;44(7):1271-7. doi: 10.1016/j.humpath.2012.10.013. Epub 2013 Jan 3. PubMed PMID: 23290008. [PubMed]（外部リンク）
  14. Kondo T, Suehara Y, Kikuta K, Kubota D, Tajima T, Mukaihara K, Ichikawa H, Kawai A. Proteomic approach toward personalized sarcoma treatment: Lessons from prognostic biomarker discovery in gastrointestinal stromal tumor. Proteomics Clin Appl. 2013 Jan;7(1-2):70-8. doi: 10.1002/prca.201200085. PMID: 23281253. [PubMed]（外部リンク）
  15. Suehara Y, Kohsaka S, Kubota D, Mukaihara K, Akaike K, Mineki R, Fujimura T, Kaneko K, Ladanyi M, Saito T, Kondo T. Proteomic Technologies to Develop Biomarkers and Functional Analyses. J Proteomics Bioinform. 2013, S3. doi: 10.4172/jpb.S3-001. [LongDom]（外部リンク）

2012

  1. Uhlén M, Oksvold P, Älgenäs C, Hamsten C, Fagerberg L, Klevebring D, Lundberg E, Odeberg J, Pontén F, Kondo T, Sivertsson Å. Antibody-based protein profiling of the human chromosome 21. Mol Cell Proteomics. 2012 Mar;11(3):M111.013458. doi:10.1074/mcp.M111.013458. Epub 2011 Oct 31. PubMed PMID: 22042635; PubMed Central PMCID: PMC3316724. [PubMed]（外部リンク）
  2. Sugihara Y, Taniguchi H, Kushima R, Tsuda H, Kubota D, Ichikawa H, Sakamoto K, Nakamura Y, Tomonaga T, Fujita S, Kondo T. Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer. J Proteomics. 2012 Sep 18;75(17):5342-55. doi:10.1016/j.jprot.2012.06.013. Epub 2012 Jun 24. PubMed PMID: 22735596. [PubMed]（外部リンク）
  3. Morofuji N, Ojima H, Onaya H, Okusaka T, Shimada K, Sakamoto Y, Esaki M, Nara S, Kosuge T, Asahina D, Ushigome M, Hiraoka N, Nagino M, Kondo T. Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinoma. J Proteomics. 2012 Feb 16;75(5):1577-89. doi: 10.1016/j.jprot.2011.11.030. Epub 2011 Dec 6. PubMed PMID: 22155129. [PubMed]（外部リンク）
  4. Mimae T, Tsuta K, Maeshima AM, Okada M, Asamura H, Kondo T, Tsuda H. Cathepsin D as a potential prognostic marker for lung adenocarcinoma. Pathol Res Pract. 2012 Sep 15;208(9):534-40. doi: 10.1016/j.prp.2012.05.020. Epub 2012 Jul 21. PubMed PMID: 22824147. [PubMed]（外部リンク）
  5. Mimae T, Tsuta K, Kondo T, Nitta H, Grogan TM, Okada M, Asamura H, Tsuda H. Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas. Ann Oncol. 2012 Dec;23(12):3129-37. doi: 10.1093/annonc/mds147. Epub 2012 Jun 13. PubMed PMID: 22700994. [PubMed]（外部リンク）
  6. Kubota D, Okubo T, Saito T, Suehara Y, Yoshida A, Kikuta K, Tsuda H, Katai H, Shimada Y, Kaneko K, Kawai A, Kondo T. Validation study on pfetin and ATP-dependent RNA helicase DDX39 as prognostic biomarkers in gastrointestinal stromal tumour. Jpn J Clin Oncol. 2012 Aug;42(8):730-41. doi: 10.1093/jjco/hys092. Epub 2012 Jun 21. PubMed PMID: 22723667. [PubMed]（外部リンク）
  7. Kikuta K, Kubota D, Saito T, Orita H, Yoshida A, Tsuda H, Suehara Y, Katai H, Shimada Y, Toyama Y, Sato K, Yao T, Kaneko K, Beppu Y, Murakami Y, Kawai A, Kondo T. Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor. J Proteomics. 2012 Feb 2;75(4):1089-98. doi: 10.1016/j.jprot.2011.10.005. Epub 2011 Oct 25. PubMed PMID: 22119546. [PubMed]（外部リンク）
  8. Ito A, Mimae T, Yamamoto YS, Hagiyama M, Nakanishi J, Ito M, Hosokawa Y, Okada M, Murakami Y, Kondo T. Novel application for pseudopodia proteomics using excimer laser ablation and two-dimensional difference gel electrophoresis. Lab Invest. 2012 Sep;92(9):1374-85. doi: 10.1038/labinvest.2012.98. Epub 2012 Jul 2. PubMed PMID: 22751350. [PubMed]（外部リンク）
  9. Huang C, Ding G, Gu C, Zhou J, Kuang M, Ji Y, He Y, Kondo T, Fan J. Decreased selenium-binding protein 1 enhances glutathione peroxidase 1 activity and downregulates HIF-1α to promote hepatocellular carcinoma invasiveness. Clin Cancer Res. 2012 Jun 1;18(11):3042-53. doi: 10.1158/1078-0432.CCR-12-0183. Epub 2012 Apr 18. PubMed PMID: 22512980. [PubMed]（外部リンク）
  10. Hosako M, Muto T, Nakamura Y, Tsuta K, Tochigi N, Tsuda H, Asamura H, Tomonaga T, Kawai A, Kondo T. Proteomic study of malignant pleural mesothelioma by laser microdissection and two-dimensional difference gel electrophoresis identified cathepsin D as a novel candidate for a differential diagnosis biomarker. J Proteomics. 2012 Jan 4;75(3):833-44. doi: 10.1016/j.jprot.2011.09.026. Epub 2011 Oct 5. PubMed PMID: 22051404. [PubMed]（外部リンク）
  11. Fujii K, Suzuki N, Ikeda K, Hamada T, Yamamoto T, Kondo T, Iwatsuki K. Proteomic study identified HSP 70 kDa protein 1A as a possible therapeutic target, in combination with histone deacetylase inhibitors, for lymphoid neoplasms. J Proteomics. 2012 Feb 2;75(4):1401-10. doi: 10.1016/j.jprot.2011.11.010. Epub 2011 Nov 20. PubMed PMID: 22123078. [PubMed]（外部リンク）
  12. Vegvari A, Kondo T, Marshall J. G. Clinical proteomics. Int J Proteomics. 2012;2012:641491. doi: 10.1155/2012/641491. Epub 2012 Aug 15. PMID: 22934184; PMCID: PMC3426226. [PubMed]（外部リンク）
  13. Suehara Y, Kubota D, Kikuta K, Kaneko K, Kawai A, Kondo T. Discovery of biomarkers for osteosarcoma by proteomics approaches. Sarcoma. 2012;2012時42分5636. doi: 10.1155/2012/425636. Epub 2012 Nov 21. PMID: 23226966; PMCID: PMC3512344. [PubMed]（外部リンク）
  14. Kondo T, Kubota D, Kawai A. Application of proteomics to soft tissue sarcomas. Int J Proteomics. 2012;2012:876401. doi: 10.1155/2012/876401. Epub 2012 Jun 19. PMID: 22778956; PMCID: PMC3388341. [PubMed]（外部リンク）

2011

  1. Suehara Y, Tochigi N, Kubota D, Kikuta K, Nakayama R, Seki K, Yoshida A, Ichikawa H, Hasegawa T, Kaneko K, Chuman H, Beppu Y, Kawai A, Kondo T. Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics. J Proteomics. 2011 May 16;74(6):829-42. doi: 10.1016/j.jprot.2011.02.033. Epub 2011 Mar 6. PubMed PMID: 21385630. [PubMed]（外部リンク）
  2. Muto T, Taniguchi H, Kushima R, Tsuda H, Yonemori H, Chen C, Sugihara Y, Sakamoto K, Kobori Y, Palmer H, Nakamura Y, Tomonaga T, Tanaka H, Mizushima H, Fujita S, Kondo T. Global expression study in colorectal cancer on proteins with alkaline isoelectric point by two-dimensional difference gel electrophoresis. J Proteomics. 2011 May 16;74(6):858-73. doi: 10.1016/j.jprot.2011.02.030. Epub 2011 Mar 6. PubMed PMID: 21385629. [PubMed]（外部リンク）
  3. Mimae T, Tsuta K, Takahashi F, Yoshida A, Kondo T, Murakami Y, Okada M, Takeuchi M, Asamura H, Tsuda H. Steroid receptor expression in thymomas and thymic carcinomas. Cancer. 2011 Oct 1;117(19):4396-405. doi: 10.1002/cncr.26061. Epub 2011 Mar 22. PubMed PMID: 21437890. [PubMed]（外部リンク）
  4. Kubota D, Orita H, Yoshida A, Gotoh M, Kanda T, Tsuda H, Hasegawa T, Katai H, Shimada Y, Kaneko K, Kawai A, Kondo T. Pfetin as a prognostic biomarker for gastrointestinal stromal tumor: validation study in multiple clinical facilities. Jpn J Clin Oncol. 2011 Oct;41(10):1194-202. doi: 10.1093/jjco/hyr121. Epub 2011 Sep 8. PubMed PMID: 21903705. [PubMed]（外部リンク）
  5. Hagiwara T, Saito Y, Nakamura Y, Tomonaga T, Murakami Y, Kondo T. Combined use of a solid-phase hexapeptide ligand library with liquid chromatography and two-dimensional difference gel electrophoresis for intact plasma proteomics. Int J Proteomics. 2011;2011:739615. doi: 10.1155/2011/739615. Epub 2011 Sep 8. PubMed PMID: 22389768; PubMed Central PMCID: PMC3282153. [PubMed]（外部リンク）
  6. Gotoh M, Arai E, Wakai-Ushijima S, Hiraoka N, Kosuge T, Hosoda F, Shibata T, Kondo T, Yokoi S, Imoto I, Inazawa J, Kanai Y. Diagnosis and prognostication of ductal adenocarcinomas of the pancreas based on genome-wide DNA methylation profiling by bacterial artificial chromosome array-based methylated CpG island amplification. J Biomed Biotechnol. 2011;2011:780836. doi: 10.1155/2011/780836. Epub 2010 Dec 21. PubMed PMID: 21197409; PubMed Central PMCID: PMC3010700. [PubMed]（外部リンク）
  7. Arai E, Wakai-Ushijima S, Fujimoto H, Hosoda F, Shibata T, Kondo T, Yokoi S, Imoto I, Inazawa J, Hirohashi S, Kanai Y. Genome-wide DNA methylation profiles in renal tumors of various histological subtypes and non-tumorous renal tissues. Pathobiology. 2011;78(1):1-9. doi: 10.1159/000322072. Epub 2011 Apr 5. PubMed PMID: 21474971. [PubMed]（外部リンク）
  8. Misek D. E, Kondo T, Duncan M. W. Proteomics-based disease biomarkers. Int J Proteomics. 2011;2011:894618. doi: 10.1155/2011/894618. Epub 2011 Oct 30. PMID: 22110951; PMCID: PMC3205713. [PubMed]（外部リンク）
  9. Kato H, Nishimura T, Ikeda N, Yamada T, Kondo T, Saijo N, Nishio K, Fujimoto J, Nomura M, Oda Y, Lindmark B, Maniwa J, Hibino H, Unno M, Ito T, Sawa Y, Tojo H, Egawa S, Edula G, Lopez M, Wigmore M, Inase N, Yoshizawa Y, Nomura F, Marko-Varga G. Developments for a growing Japanese patient population: facilitating new technologies for future health care. J Proteomics. 2011 May 16;74(6):759-64. doi: 10.1016/j.jprot.2010.12.006. Epub 2010 Dec 22. PMID: 21184850. [PubMed]（外部リンク）

2010

  1. Shibata T, Kokubu A, Miyamoto M, Hosoda F, Gotoh M, Tsuta K, Asamura H, Matsuno Y, Kondo T, Imoto I, Inazawa J, Hirohashi S. DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lung. Oncogene. 2010 Aug 19;29(33):4671-81. doi: 10.1038/onc.2010.217. Epub 2010 Jun 14. PubMed PMID: 20543864. [PubMed]（外部リンク）
  2. Ojima H, Yoshikawa D, Ino Y, Shimizu H, Miyamoto M, Kokubu A, Hiraoka N, Morofuji N, Kondo T, Onaya H, Okusaka T, Shimada K, Sakamoto Y, Esaki M, Nara S, Kosuge T, Hirohashi S, Kanai Y, Shibata T. Establishment of six new human biliary tract carcinoma cell lines and identification of MAGEH1 as a candidate biomarker for predicting the efficacy of gemcitabine treatment. Cancer Sci. 2010 Apr;101(4):882-8. doi: 10.1111/j.1349 7006.2009.01462.x. Epub 2009 Dec 8. PubMed PMID: 20088962. [PubMed]（外部リンク）
  3. Nishiyama N, Arai E, Chihara Y, Fujimoto H, Hosoda F, Shibata T, Kondo T, Tsukamoto T, Yokoi S, Imoto I, Inazawa J, Hirohashi S, Kanai Y. Genome-wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage. Cancer Sci. 2010 Jan;101(1):231-40. doi: 10.1111/j.1349-7006.2009.01330.x. Epub 2009 Aug 27. PMID: 19775289; PMCID: PMC11159941. [PubMed]（外部リンク）
  4. Kikuta K, Tochigi N, Saito S, Shimoda T, Morioka H, Toyama Y, Hosono A, Suehara Y, Beppu Y, Kawai A, Hirohashi S, Kondo T. Peroxiredoxin 2 as a chemotherapy responsiveness biomarker candidate in osteosarcoma revealed by proteomics. Proteomics Clin Appl. 2010 May;4(5):560-7. doi: 10.1002/prca.200900172. Epub 2010 Feb 26. PubMed PMID: 21137073. [PubMed]（外部リンク）
  5. Kikuta K, Gotoh M, Kanda T, Tochigi N, Shimoda T, Hasegawa T, Katai H, Shimada Y, Suehara Y, Kawai A, Hirohashi S, Kondo T. Pfetin as a prognostic biomarker in gastrointestinal stromal tumor: novel monoclonal antibody and external validation study in multiple clinical facilities. Jpn J Clin Oncol. 2010 Jan;40(1):60-72. doi: 10.1093/jjco/hyp125. Epub 2009 Oct 7. PubMed PMID: 19815537. [PubMed]（外部リンク）
  6. Akishima-Fukasawa Y, Ino Y, Nakanishi Y, Miura A, Moriya Y, Kondo T, Kanai Y, Hirohashi S. Significance of PGP9.5 expression in cancer-associated fibroblasts for prognosis of colorectal carcinoma. Am J Clin Pathol. 2010 Jul;134(1):71-9. doi: 10.1309/AJCPRJP39MIDSGBH. PubMed PMID: 20551269. [PubMed]（外部リンク）
  7. Kondo T. Cancer proteome-expression database: Genome Medicine Database of Japan Proteomics. Expert Rev Proteomics. 2010;7(1):21-7. doi: 10.1586/epr.09.87. Review. PMID: 20121473. [PubMed]（外部リンク）

2009

  1. Yamada M, Fjii K, Koyama K, Hirohashi S, Kondo T. The proteomic profile of pancreatic cancer cell lines corresponding to carcinogenesis and metastasis. J Proteomics Bioinform. 2009;2(1):1-18. PMID: 1000057. [LongDom]（外部リンク）
  2. Uemura N, Nakanishi Y, Kato H, Saito S, Nagino M, Hirohashi S, Kondo T. Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics. Int J Cancer. 2009 May 1;124(9):2106-15. doi: 10.1002/ijc.24194. PMID: 19142970. [PubMed]（外部リンク）
  3. Uemura N, Nakanishi Y, Kato H, Nagino M, Hirohashi S, Kondo T. Antibody-based proteomics for esophageal cancer: Identification of proteins in the nuclear factor-kappaB pathway and mitotic checkpoint. Cancer Sci. 2009 Sep;100(9):1612-22. doi: 10.1111/j.1349-7006.2009.01230.x. Epub 2009 May 28. PMID: 19558549; PMCID: PMC11159346. [PubMed]（外部リンク）
  4. Tsuta K, Kato Y, Tochigi N, Hoshino T, Takeda Y, Hosako M, Maeshima AM, Asamura H, Kondo T, Matsuno Y. Comparison of different clones (WT49 versus 6F-H2) of WT-1 antibodies for immunohistochemical diagnosis of malignant pleural mesothelioma. Appl Immunohistochem Mol Morphol. 2009 Mar;17(2):126-30. doi: 10.1097/PAI.0b013e318187dd26. PubMed PMID: 19516197. [PubMed]（外部リンク）
  5. Suehara Y, Kikuta K, Nakayama R, Fujii K, Ichikawa H, Shibata T, Seki K, Hasegawa T, Gotoh M, Tochigi N, Shimoda T, Shimada Y, Sano T, Beppu Y, Kurosawa H, Hirohashi S, Kawai A, Kondo T. Anatomic site-specific proteomic signatures of gastrointestinal stromal tumors. Proteomics Clin Appl. 2009;3(5):584-96. [Wiley Online Library]（外部リンク）
  6. Suehara Y, Kikuta K, Nakayama R, Fujii K, Ichikawa H, Shibata T, Seki K, Hasegawa T, Gotoh M, Tochigi N, Shimoda T, Shimada Y, Sano T, Beppu Y, Kurosawa H, Hirohashi S, Kawai A, Kondo T. GST-P1 as a hitological biomarker of synovial sarcoma revealed by proteomics. Proteomics Clin Appl. 2009;3(5):623-34. [Wiley Online Library]（外部リンク）
  7. Kosaihira S, Tsunehiro Y, Tsuta K, Tochigi N, Gemma A, Hirohashi S, Kondo T. Proteome expression database of lung adenocarcinoma: a segment of the genome medicine database of Japan proteomics. J Proteomics Bioinform. 2009;2(11):463-5. PMID: 1000106. [LongDom]（外部リンク）
  8. Kondo T, Hirohashi S. Application of 2D-DIGE in cancer proteomics toward personalized medicine. Methods Mol Biol. 2009;577:135-54. doi:10.1007/978-1-60761-232-2_11. PubMed PMID: 19718514. [PubMed]（外部リンク）
  9. Kikuta K, Tsunehiro Y, Yoshida A, Tochigi N, Hirohashi S, Kawai A, Kondo T. Proteome expression database of Ewing sarcoma: a segment of the genome medicine database of Japan proteomics. J Proteomics Bioinform. 2009;2(12):500-4. PMID: 1000112. [LongDom]（外部リンク）
  10. Kikuta K, Tochigi N, Shimoda T, Yabe H, Morioka H, Toyama Y, Hosono A, Beppu Y, Kawai A, Hirohashi S, Kondo T. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics. Clin Cancer Res. 2009 Apr 15;15(8):2885-94. doi: 10.1158/1078-0432.CCR-08-1913. Epub 2009 Apr 7. PubMed PMID: 19351769. [PubMed]（外部リンク）
  11. Harada C, Tajima H, Hirohashi S, Kondo T. Toward high performance western blotting using vacuum-driven system and laser scanner; comparison between two signal detection methods based on chemiluminescent and immunofluorescent imaging. J Electrophoresis. 2009;53(63). [J-Stage]（外部リンク）
  12. Arai E, Ushijima S, Gotoh M, Ojima H, Kosuge T, Hosoda F, Shibata T, Kondo T, Yokoi S, Imoto I, Inazawa J, Hirohashi S, Kanai Y. Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma. Int J Cancer. 2009 Dec 15;125(12):2854-62. doi: 10.1002/ijc.24708. PMID: 19569176. [PubMed]（外部リンク）
  13. Arai E, Ushijima S, Fujimoto H, Hosoda F, Shibata T, Kondo T, Yokoi S, Imoto I, Inazawa J, Hirohashi S, Kanai Y. Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome. Carcinogenesis. 2009 Feb;30(2):214-21. doi: 10.1093/carcin/bgn268. Epub 2008 Nov 26. PubMed PMID: 19037089; PubMed Central PMCID: PMC2639047. [PubMed]（外部リンク）
  14. Kondo T, Hirohashi S. Application of 2D-DIGE in cancer proteomics toward personalized medicine. Methods Mol Biol. 2009;577:135-54. doi: 10.1007/978-1-60761-232-2_11. PubMed PMID: 19718514. [PubMed]（外部リンク）

2008

  1. Suehara Y, Kondo T, Seki K, Shibata T, Fujii K, Gotoh M, Hasegawa T, Shimada Y, Sasako M, Shimoda T, Kurosawa H, Beppu Y, Kawai A, Hirohashi S. Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics. Clin Cancer Res. 2008 Mar 15;14(6):1707-17. doi: 10.1158/1078-0432.CCR-07-1478. PubMed PMID: 18347171. [PubMed]（外部リンク）
  2. Saito S, Ojima H, Ichikawa H, Hirohashi S, Kondo T. Molecular background of alpha-fetoprotein in liver cancer cells as revealed by global RNA expression analysis. Cancer Sci. 2008 Dec;99(12):2402-9. doi: 10.1111/j.1349-7006.2008.00973.x. Epub 2008 Nov 24. PMID: 19038010; PMCID: PMC11158806. [PubMed]（外部リンク）
  3. Orimo T, Ojima H, Hiraoka N, Saito S, Kosuge T, Kakisaka T, Yokoo H, Nakanishi K, Kamiyama T, Todo S, Hirohashi S, Kondo T. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma. Hepatology. 2008 Dec;48(6):1851-63. doi: 10.1002/hep.22552. PMID: 18937283. [PubMed]（外部リンク）
  4. Arai E, Ushijima S, Tsuda H, Fujimoto H, Hosoda F, Shibata T, Kondo T, Imoto I, Inazawa J, Hirohashi S, Kanai Y. Genetic clustering of clear cell renal cell carcinoma based on array-comparative genomic hybridization: its association with DNA methylation alteration and patient outcome. Clin Cancer Res. 2008 Sep 1;14(17):5531-9. doi: 10.1158/1078-0432.CCR-08-0443. PMID: 18765545. [PubMed]（外部リンク）
  5. Kondo T. Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE. BMB Rep. 2008 Sep 30;41(9):626-34. doi: 10.5483/bmbrep.2008.41.9.626. PMID: 18823585. [PubMed]（外部リンク）
  6. Kondo T. Cancer proteomics for biomarker development. J Proteomics Bioinform. 2008;1(9):477-84. [LongDom]（外部リンク）
  7. Kawai A, Kondo T, Suehara Y, Kikuta K, Hirohashi S. Global protein-expression analysis of bone and soft tissue sarcomas. Clin Orthop Relat Res. 2008 Sep;466(9):2099-106. doi: 10.1007/s11999-008-0330-4. Epub 2008 Jun 6. PMID: 18535868; PMCID: PMC2493021. [PubMed]（外部リンク）

2007

  1. Katoh H, Ojima H, Kokubu A, Saito S, Kondo T, Kosuge T, Hosoda F, Imoto I, Inazawa J, Hirohashi S, Shibata T. Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets. Gastroenterology. 2007 Nov;133(5):1475-86. doi: 10.1053/j.gastro.2007.08.038. PMID: 17983802. [PubMed]（外部リンク）
  2. Kakisaka T, Kondo T, Okano T, Fujii K, Honda K, Endo M, Tsuchida A, Aoki T, Itoi T, Moriyasu F, Yamada T, Kato H, Nishimura T, Todo S, Hirohashi S. Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):257-67. doi: 10.1016/j.jchromb.2007.01.029. Epub 2007 Feb 1. PMID: 17303479; PMCID: PMC7105233. [PubMed]（外部リンク）
  3. Yokoo H, Kondo T, Okano T, Nakanishi K, Sakamoto M, Kosuge T, Todo S, Hirohashi S. Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery. Cancer Sci. 2007 May;98(5):665-73. doi: 10.1111/j.1349-7006.2007.00441.x. Epub 2007 Mar 28. PMID: 17391314; PMCID: PMC11159521. [PubMed]（外部リンク）
  4. Okano T, Kondo T, Fujii K, Nishimura T, Takano T, Ohe Y, Tsuta K, Matsuno Y, Gemma A, Kato H, Kudoh S, Hirohashi S. Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma. Clin Cancer Res. 2007 Feb 1;13(3):799-805. doi: 10.1158/1078-0432.CCR-06-1654. PMID: 17289870. [PubMed]（外部リンク）

  5. Kondo T, Hirohashi S. Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomics. Nat Protoc. 2006;1(6):2940-56. doi: 10.1038/nprot.2006.421. PMID: 17406554. [PubMed]（外部リンク）

2006

  1. Suehara Y, Kondo T, Fujii K, Hasegawa T, Kawai A, Seki K, Beppu Y, Nishimura T, Kurosawa H, Hirohashi S. Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas. Proteomics. 2006 Aug;6(15):4402-9. doi: 10.1002/pmic.200600196. PMID: 16807943. [PubMed]（外部リンク）
  2. Okano T, Kondo T, Kakisaka T, Fujii K, Yamada M, Kato H, Nishimura T, Gemma A, Kudoh S, Hirohashi S. Plasma proteomics of lung cancer by a linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis. Proteomics. 2006 Jul;6(13):3938-48. doi: 10.1002/pmic.200500883. PMID: 16767791. [PubMed]（外部リンク）
  3. Hatakeyama H, Kondo T, Fujii K, Nakanishi Y, Kato H, Fukuda S, Hirohashi S. Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics. 2006 Dec;6(23):6300-16. doi: 10.1002/pmic.200600488. PMID: 17133371. [PubMed]（外部リンク）
  4. Fujii K, Kondo T, Yokoo H, Okano T, Yamada M, Yamada T, Iwatsuki K, Hirohashi S. Database of two-dimensional polyacrylamide gel electrophoresis of proteins labeled with CyDye DIGE Fluor saturation dye. Proteomics. 2006 Mar;6(5):1640-53. doi: 10.1002/pmic.200401346. PMID: 16429455. [PubMed]（外部リンク）
  5. Fujii K, Kondo T, Yamada M, Iwatsuki K, Hirohashi S. Toward a comprehensive quantitative proteome database: protein expression map of lymphoid neoplasms by 2-D DIGE and MS. Proteomics. 2006 Sep;6(17):4856-76. doi: 10.1002/pmic.200600097. PMID: 16888764. [PubMed]（外部リンク）

2005

  1. Shibata T, Uryu S, Kokubu A, Hosoda F, Ohki M, Sakiyama T, Matsuno Y, Tsuchiya R, Kanai Y, Kondo T, Imoto I, Inazawa J, Hirohashi S. Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features. Clin Cancer Res. 2005 Sep 1;11(17):6177-85. doi: 10.1158/1078-0432.CCR-05-0293. PMID: 16144918. [PubMed]（外部リンク）
  2. Seike M, Kondo T, Fujii K, Okano T, Yamada T, Matsuno Y, Gemma A, Kudoh S, Hirohashi S. Proteomic signatures for histological types of lung cancer. Proteomics. 2005 Jul;5(11):2939-48. doi: 10.1002/pmic.200401166. PMID: 15996008. [PubMed]（外部リンク）
  3. Naishiro Y, Yamada T, Idogawa M, Honda K, Takada M, Kondo T, Imai K, Hirohashi S. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein. Oncogene. 2005 Apr 28;24(19):3141-53. doi: 10.1038/sj.onc.1208517. PMID: 15735679. [PubMed]（外部リンク）
  4. Mori Y, Kondo T, Yamada T, Tsuchida A, Aoki T, Hirohashi S. Two-dimensional electrophoresis database of fluorescence-labeled proteins of colon cancer cells. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Sep 5;823(2):82-97. doi: 10.1016/j.jchromb.2005.05.024. PMID: 16011914. [PubMed]（外部リンク）
  5. Katoh H, Shibata T, Kokubu A, Ojima H, Loukopoulos P, Kanai Y, Kosuge T, Fukayama M, Kondo T, Sakamoto M, Hosoda F, Ohki M, Imoto I, Inazawa J, Hirohashi S. Genetic profile of hepatocellular carcinoma revealed by array-based comparative genomic hybridization: identification of genetic indicators to predict patient outcome. J Hepatol. 2005 Nov;43(5):863-74. doi: 10.1016/j.jhep.2005.05.033. Epub 2005 Jul 5. PMID: 16139920. [PubMed]（外部リンク）
  6. Fujii K, Kondo T, Yokoo H, Yamada T, Matsuno Y, Iwatsuki K, Hirohashi S. Protein expression pattern distinguishes different lymphoid neoplasms. Proteomics. 2005 Nov;5(16):4274-86. doi: 10.1002/pmic.200401286. PMID: 16206328. [PubMed]（外部リンク）
  7. Fujii K, Kondo T, Yokoo H, Yamada T, Iwatsuki K, Hirohashi S. Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. Proteomics. 2005 Apr;5(5):1411-22. doi: 10.1002/pmic.200401004. PMID: 15751005. [PubMed]（外部リンク）

2004

  1. Yokoo H, Kondo T, Fujii K, Yamada T, Todo S, Hirohashi S. Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells. Hepatology. 2004 Sep;40(3):609-17. doi: 10.1002/hep.20372. PMID: 15349899. [PubMed]（外部リンク）
  2. Seike M, Kondo T, Fujii K, Yamada T, Gemma A, Kudoh S, Hirohashi S. Proteomic signature of human cancer cells. Proteomics. 2004 Sep;4(9):2776-88. doi: 10.1002/pmic.200300795. PMID: 15352251. [PubMed]（外部リンク）
  3. Honda K, Yamada T, Seike M, Hayashida Y, Idogawa M, Kondo T, Ino Y, Hirohashi S. Alternative splice variant of actinin-4 in small cell lung cancer. Oncogene. 2004 Jul 1;23(30):5257-62. doi: 10.1038/sj.onc.1207652. PMID: 15122314. [PubMed]（外部リンク）

2003

  1. Yamada T, Mori Y, Hayashi R, Takada M, Ino Y, Naishiro Y, Kondo T, Hirohashi S. Suppression of intestinal polyposis in Mdr1-deficient ApcMin/+ mice. Cancer Res. 2003 Mar 1;63(5):895-901. PMID: 12615699. [PubMed]（外部リンク）
  2. Seike M, Kondo T, Mori Y, Gemma A, Kudoh S, Sakamoto M, Yamada T, Hirohashi S. Proteomic analysis of intestinal epithelial cells expressing stabilized beta-catenin. Cancer Res. 2003 Aug 1;63(15):4641-7. PMID: 12907644. [PubMed]（外部リンク）
  3. Kondo T, Seike M, Mori Y, Fujii K, Yamada T, Hirohashi S. Application of sensitive fluorescent dyes in linkage of laser microdissection and two-dimensional gel electrophoresis as a cancer proteomic study tool. Proteomics. 2003 Sep;3(9):1758-66. doi: 10.1002/pmic.200300531. PMID: 12973736. [PubMed]（外部リンク）
発表業績
  • 研究概要集のバナー
  • Our Research Focusのバナー